Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis

Objective: To measure the relationship between lactate and mortality in hospital inpatients. Main outcomes of interest were 3-day, 30-day, and 1-year all-cause mortality. Design: Retrospective cohort study, October 2011 to September 2013. Setting: University-affiliated US Veterans Affairs Hospital....

Full description

Bibliographic Details
Main Authors: Julian Villar, Jack H Short, Geoffrey Lighthall
Format: Article
Language:English
Published: SAGE Publishing 2019-08-01
Series:Infectious Diseases
Online Access:https://doi.org/10.1177/1178633719862776
id doaj-91dd6dd8b1c8450b9a819573de0b4406
record_format Article
spelling doaj-91dd6dd8b1c8450b9a819573de0b44062020-11-25T02:54:21ZengSAGE PublishingInfectious Diseases1178-63372019-08-011210.1177/1178633719862776Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without SepsisJulian Villar0Jack H Short1Geoffrey Lighthall2Department of Internal Medicine, Stanford University School of Medicine, Stanford, CA, USADepartment of Internal Medicine, Stanford University School of Medicine, Stanford, CA, USADepartment of Anesthesia, Pain and Perioperative Medicine, Stanford University School of Medicine, Stanford, CA, USAObjective: To measure the relationship between lactate and mortality in hospital inpatients. Main outcomes of interest were 3-day, 30-day, and 1-year all-cause mortality. Design: Retrospective cohort study, October 2011 to September 2013. Setting: University-affiliated US Veterans Affairs Hospital. Patients: All inpatients with lactate level measured during the study period. Measurements: Analysis of peak lactate level (mmol/L) during the most recent admission for patients who died, and peak lactate level during an admission for surviving patients. Covariates including sepsis, ICU admission, code blue and rapid response calls, medical vs surgical ward, liver disease, kidney disease, and hospice status were recorded. Results: In total, 3325 inpatients were included; 564 patients had sepsis. Median lactate 1.7 mmol/L (interquartile range [IQR] 1.2-2.6). The 3-day, 30-day, and 1-year mortality were 2.5%, 10%, and 24%, respectively. A lactate level cutoff of ⩾4 mmol/L had best test characteristics (sensitivity 52.4%, specificity 91.4%) to predict increased 3-day mortality. Unadjusted risk ratio of death in 3 days for lactate ⩾4 was 10.3 (95% confidence interval [CI] 6.8-15.7). Patients with sepsis had a consistently higher risk of death compared with patients without sepsis for any given level of lactate. Adjusted odds ratio (OR) of 3-day mortality for lactate ⩾4 was 7.6 (95% CI 4.6-12.5); 30-day mortality was 2.6 (95% CI 1.9-3.6); and 1-year mortality was 1.8 (95% CI 1.4-2.6). Lactates in the normal range (<1.7) were also independently associated with 30-day and 1-year mortality. Conclusions: Lactate predicts risk of death in all patients, although patients with sepsis have a higher mortality for any given lactate level. We report the novel finding that serum lactate, including normal values, is associated with long-term mortality.https://doi.org/10.1177/1178633719862776
collection DOAJ
language English
format Article
sources DOAJ
author Julian Villar
Jack H Short
Geoffrey Lighthall
spellingShingle Julian Villar
Jack H Short
Geoffrey Lighthall
Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis
Infectious Diseases
author_facet Julian Villar
Jack H Short
Geoffrey Lighthall
author_sort Julian Villar
title Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis
title_short Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis
title_full Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis
title_fullStr Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis
title_full_unstemmed Lactate Predicts Both Short- and Long-Term Mortality in Patients With and Without Sepsis
title_sort lactate predicts both short- and long-term mortality in patients with and without sepsis
publisher SAGE Publishing
series Infectious Diseases
issn 1178-6337
publishDate 2019-08-01
description Objective: To measure the relationship between lactate and mortality in hospital inpatients. Main outcomes of interest were 3-day, 30-day, and 1-year all-cause mortality. Design: Retrospective cohort study, October 2011 to September 2013. Setting: University-affiliated US Veterans Affairs Hospital. Patients: All inpatients with lactate level measured during the study period. Measurements: Analysis of peak lactate level (mmol/L) during the most recent admission for patients who died, and peak lactate level during an admission for surviving patients. Covariates including sepsis, ICU admission, code blue and rapid response calls, medical vs surgical ward, liver disease, kidney disease, and hospice status were recorded. Results: In total, 3325 inpatients were included; 564 patients had sepsis. Median lactate 1.7 mmol/L (interquartile range [IQR] 1.2-2.6). The 3-day, 30-day, and 1-year mortality were 2.5%, 10%, and 24%, respectively. A lactate level cutoff of ⩾4 mmol/L had best test characteristics (sensitivity 52.4%, specificity 91.4%) to predict increased 3-day mortality. Unadjusted risk ratio of death in 3 days for lactate ⩾4 was 10.3 (95% confidence interval [CI] 6.8-15.7). Patients with sepsis had a consistently higher risk of death compared with patients without sepsis for any given level of lactate. Adjusted odds ratio (OR) of 3-day mortality for lactate ⩾4 was 7.6 (95% CI 4.6-12.5); 30-day mortality was 2.6 (95% CI 1.9-3.6); and 1-year mortality was 1.8 (95% CI 1.4-2.6). Lactates in the normal range (<1.7) were also independently associated with 30-day and 1-year mortality. Conclusions: Lactate predicts risk of death in all patients, although patients with sepsis have a higher mortality for any given lactate level. We report the novel finding that serum lactate, including normal values, is associated with long-term mortality.
url https://doi.org/10.1177/1178633719862776
work_keys_str_mv AT julianvillar lactatepredictsbothshortandlongtermmortalityinpatientswithandwithoutsepsis
AT jackhshort lactatepredictsbothshortandlongtermmortalityinpatientswithandwithoutsepsis
AT geoffreylighthall lactatepredictsbothshortandlongtermmortalityinpatientswithandwithoutsepsis
_version_ 1724721800157331456